A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
Clinical trial NCT00478777 · COMPLETED
Trial details
- NCT number
- NCT00478777
- Sponsor
- Celgene Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2007-11-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.